Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 4 Garg Pushkal (CMO & EVP Dev & Med Affairs) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 4,518 shares @ $0
Granted 3,109 shares @ $0
Sold 658 shares @ $184.7, valued at $121.5k
Sold 1,593 shares @ $185.54, valued at $295.6k
Sold 945 shares @ $186.39, valued at $176.1k
Sold 86 shares @ $187.37, valued at $16.1k
Sold 15 shares @ $188.4, valued at $2.8k
Sold 164 shares @ $189.31, valued at $31k
Sold 3,112 shares @ $183.58, valued at $571.3k
Sold 814 shares @ $184.65, valued at $150.3k
Sold 240 shares @ $185.32, valued at $44.5k
08/07/2023 4 Poulton Jeffrey V. (EVP, CFO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 4,518 shares @ $0
Granted 3,109 shares @ $0
Sold 658 shares @ $184.7, valued at $121.5k
Sold 1,593 shares @ $185.54, valued at $295.6k
Sold 944 shares @ $186.39, valued at $176k
Sold 86 shares @ $187.37, valued at $16.1k
Sold 15 shares @ $188.4, valued at $2.8k
Sold 164 shares @ $189.31, valued at $31k
08/07/2023 4 Greenstreet Yvonne (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 5,082 shares @ $0
Granted 3,859 shares @ $0
Sold 771 shares @ $184.7, valued at $142.4k
Sold 1,869 shares @ $185.54, valued at $346.8k
Sold 1,107 shares @ $186.39, valued at $206.3k
Sold 101 shares @ $187.37, valued at $18.9k
Sold 17 shares @ $188.4, valued at $3.2k
Sold 192 shares @ $189.31, valued at $36.3k
08/07/2023 4 Vaishnaw Akshay (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 5,082 shares @ $0
Granted 3,859 shares @ $0
Sold 771 shares @ $184.7, valued at $142.4k
Sold 1,869 shares @ $185.54, valued at $346.8k
Sold 1,107 shares @ $186.39, valued at $206.3k
Sold 101 shares @ $187.37, valued at $18.9k
Sold 17 shares @ $188.4, valued at $3.2k
Sold 192 shares @ $189.31, valued at $36.3k
08/04/2023 4 BONNEY MICHAEL W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Sold 300 shares @ $181.08, valued at $54.3k
Sold 500 shares @ $182.45, valued at $91.2k
Sold 560 shares @ $183.75, valued at $102.9k
Sold 1,535 shares @ $184.89, valued at $283.8k
Sold 1,714 shares @ $185.99, valued at $318.8k
Sold 1,389 shares @ $187.04, valued at $259.8k
Sold 450 shares @ $187.71, valued at $84.5k
Exercised 22,477 restricted stock units @ $0
05/19/2023 4 PYOTT DAVID E I (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 Sigal Charles Elliott (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 BRANDICOURT OLIVIER (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 HAMBURG MARGARET A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 Reitan Colleen F (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 SCHULMAN AMY W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 Ausiello Dennis A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 Fanucci Marsha (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 BONNEY MICHAEL W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
05/19/2023 4 SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,454 options to buy @ $189.87, valued at $655.8k
04/28/2023 4 Greenstreet Yvonne (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 16,952 shares @ $0
Sold 628 shares @ $193.18, valued at $121.3k
Sold 2,898 shares @ $193.93, valued at $562k
Sold 3,225 shares @ $194.94, valued at $628.7k
Sold 331 shares @ $195.65, valued at $64.8k
Sold 533 shares @ $197.08, valued at $105k
04/28/2023 4 Poulton Jeffrey V. (EVP, CFO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,277 shares @ $0
Sold 81 shares @ $193.18, valued at $15.6k
Sold 372 shares @ $193.93, valued at $72.1k
Sold 414 shares @ $194.94, valued at $80.7k
Sold 42 shares @ $195.65, valued at $8.2k
Sold 68 shares @ $197.08, valued at $13.4k
04/28/2023 4 Tanguler Tolga (EVP, Chief Commercial Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 3,277 shares @ $0
Sold 122 shares @ $193.18, valued at $23.6k
Sold 562 shares @ $193.93, valued at $109k
Sold 625 shares @ $194.94, valued at $121.8k
Sold 64 shares @ $195.65, valued at $12.5k
Sold 103 shares @ $197.08, valued at $20.3k
04/28/2023 4 Vaishnaw Akshay (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 5,312 shares @ $0
Sold 197 shares @ $193.18, valued at $38.1k
Sold 910 shares @ $193.93, valued at $176.5k
Sold 1,013 shares @ $194.94, valued at $197.5k
Sold 104 shares @ $195.65, valued at $20.3k
Sold 168 shares @ $197.08, valued at $33.1k
04/28/2023 4 Garg Pushkal (CMO & EVP Dev & Med Affairs) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 4,294 shares @ $0
Sold 151 shares @ $193.18, valued at $29.2k
Sold 700 shares @ $193.93, valued at $135.8k
Sold 779 shares @ $194.94, valued at $151.9k
Sold 80 shares @ $195.65, valued at $15.7k
Sold 129 shares @ $197.08, valued at $25.4k
Sold 204 shares @ $195.46, valued at $39.9k
Sold 103 shares @ $196.62, valued at $20.3k
Sold 715 shares @ $198.03, valued at $141.6k
Sold 385 shares @ $199.54, valued at $76.8k
Sold 955 shares @ $200.35, valued at $191.3k
03/09/2023 4 KELLOGG PETER N (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 4,948 options to buy @ $194.34, valued at $961.6k
03/09/2023 3 KELLOGG PETER N (Director) has filed a Form 3 on ALNYLAM PHARMACEUTICALS, INC.
03/07/2023 4 Garg Pushkal (CMO & EVP Dev & Med Affairs) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Sold 18,072 shares @ $200, valued at $3.6M
Exercised 2,500 options to buy @ $96.45, valued at $241.1k
03/01/2023 4 Greenstreet Yvonne (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 17,763 restricted stock units @ $0
Granted 36,775 options to buy @ $190.01, valued at $7M
03/01/2023 4 Vaishnaw Akshay (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 5,790 restricted stock units @ $0
Granted 11,986 options to buy @ $190.01, valued at $2.3M
03/01/2023 4 Garg Pushkal (CMO & EVP Dev & Med Affairs) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 5,724 restricted stock units @ $0
Granted 11,850 options to buy @ $190.01, valued at $2.3M
03/01/2023 4 Poulton Jeffrey V. (EVP, CFO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 5,724 restricted stock units @ $0
Granted 11,850 options to buy @ $190.01, valued at $2.3M
03/01/2023 4 Tanguler Tolga (EVP, Chief Commercial Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 5,000 restricted stock units @ $0
Granted 10,352 options to buy @ $190.01, valued at $2M
03/01/2023 4 Franchini Indrani Lall (EVP, CLO & Secretary) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 2,632 restricted stock units @ $0
Granted 5,449 options to buy @ $190.01, valued at $1M
02/27/2023 4 SCHULMAN AMY W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Exercised 136 restricted stock units @ $0
02/27/2023 4 PYOTT DAVID E I (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Exercised 136 restricted stock units @ $0
02/27/2023 4 HAMBURG MARGARET A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Exercised 136 restricted stock units @ $0
02/27/2023 4 Fanucci Marsha (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Exercised 136 restricted stock units @ $0
02/27/2023 4 Ausiello Dennis A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Exercised 136 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy